Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) was upgraded by investment analysts at Citizens Jmp from a “hold” rating to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports.
SBRA has been the topic of a number of other reports. Mizuho reiterated a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and raised their price target for the company from $17.00 to $20.00 in a report on Friday, September 13th. Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $16.00 to $20.00 in a report on Tuesday, October 1st. Scotiabank upped their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th. Finally, JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research note on Tuesday. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $19.25.
View Our Latest Report on SBRA
Sabra Health Care REIT Trading Up 1.0 %
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The company had revenue of $178.00 million for the quarter, compared to the consensus estimate of $177.19 million. During the same period in the prior year, the company earned $0.34 EPS. Analysts expect that Sabra Health Care REIT will post 1.39 EPS for the current fiscal year.
Institutional Trading of Sabra Health Care REIT
A number of hedge funds have recently made changes to their positions in the business. Quarry LP bought a new stake in Sabra Health Care REIT in the 3rd quarter valued at $30,000. Assetmark Inc. raised its position in shares of Sabra Health Care REIT by 168.4% in the third quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 1,231 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in shares of Sabra Health Care REIT during the 3rd quarter worth about $59,000. Harbor Capital Advisors Inc. bought a new stake in shares of Sabra Health Care REIT during the 3rd quarter worth about $78,000. Finally, GAMMA Investing LLC grew its stake in Sabra Health Care REIT by 25.3% in the 3rd quarter. GAMMA Investing LLC now owns 4,614 shares of the real estate investment trust’s stock valued at $86,000 after buying an additional 932 shares during the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.
Sabra Health Care REIT Company Profile
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Featured Stories
- Five stocks we like better than Sabra Health Care REIT
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 100% Upside? Amprius Technologies Is Charged for Growth in 2025
- How to Most Effectively Use the MarketBeat Earnings Screener
- The 5 Stocks Congress Bought Most in 2024: Top Picks for 2025
- Best Stocks Under $5.00
- 3 Stocks Set to Benefit From Trump’s “Drill, Baby, Drill” Policy
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.